...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal
【24h】

Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal

机译:塞内加尔婴幼儿间歇预防治疗(IPTi / c)后抗疟药耐药性的选择

获取原文
获取原文并翻译 | 示例
           

摘要

Our study investigated the possible impact of SP-IPT given to infants and children on the prevalence of SP-resistant haplotypes in the Plasmodium falciparum genes Pfdhfr and Pfdhps, comparing sites with and without IPTi/c. P. falciparum positive samples (N = 352) collected from children < 5 years were analyzed to determine the prevalence of SP resistance-related haplotypes by nested PCR followed by sequence-specific oligonucleotide probe-enzyme-linked immunosorbent assay. The prevalence of the Pfdhfr triple mutant haplotype (CIRN) increased in both groups, but only significantly in the IPTi/c group from 41% to 65% in 2011 (P = 0.005). Conversely, the Pfdhps 437G mutation decreased in both groups from 44.6% to 28.6% (P = 0.07) and from 66.7% to 47.5% (P = 0.02) between 2010 and 2011 in the control and the IPTi/c groups, respectively. A weak trend for decreasing prevalence of quadruple mutants (triple Pfdhfr + Pfdhps 437G) was noted in both groups (P = 0.15 and P = 0.34). During the two cross-sectional surveys some significant changes were observed in the SP resistance-related genes.
机译:我们的研究调查了婴幼儿SP-IPT对恶性疟原虫基因Pfdhfr和Pfdhps中SP抵抗单倍型的普遍性的可能影响,比较有IPTi / c和无IPTi / c的位点。通过嵌套PCR,然后通过序列特异性寡核苷酸探针-酶联免疫吸附测定,分析了从5岁以下儿童收集的恶性疟原虫阳性样品(N = 352),以确定与SP耐药相关的单倍型的患病率。两组中Pfdhfr三突变体单倍型(CIRN)的患病率均增加,但IPTi / c组中的患病率仅从2011年的41%显着提高到65%(P = 0.005)。相反,对照组和IPTi / c组的Pfdhps 437G突变在2010年至2011年期间分别从44.6%降低到28.6%(P = 0.07),从66.7%降低到47.5%(P = 0.02)。在两组中都发现了降低四重突变体(三重Pfdhfr + Pfdhps 437G)患病率的弱趋势(P = 0.15和P = 0.34)。在两次横断面调查中,观察到SP抗性相关基因发生了一些显着变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号